Results 141 to 150 of about 64,832 (295)

Phase II study of pregabalin for the prevention of chemotherapy induced nausea and vomiting

open access: yesO Mundo da Saúde
To evaluate the role of pregabalin in the protection of chemotherapy-induced nausea and vomiting, we performed a phase II randomized, double-blind, placebo-controlled trial to investigate whether pregabalin could improve the complete control of nausea ...
Carla Santos Rossi Paniquar   +3 more
doaj   +1 more source

Coping With Chronic Illness: A Systematic Review of Adaptive Strategies Across Cancer, COPD, Diabetes and Heart Disease

open access: yesPublic Health Challenges, Volume 4, Issue 4, December 2025.
This systematic review explores how individuals with cancer, chronic obstructive pulmonary disease (COPD), diabetes and coronary heart disease adapt to the complex challenges posed by chronic illness. The review was designed to identify, categorise and compare coping strategies across these conditions, while also examining how personal experiences ...
Andrew Kweku Conduah   +2 more
wiley   +1 more source

Urothelial carcinoma: Perioperative considerations from top to bottom

open access: yesCA: A Cancer Journal for Clinicians, Volume 75, Issue 6, Page 528-551, November/December 2025.
Abstract Urothelial carcinoma is an aggressive entity that is associated with significant morbidity, but there have been major advances in both our understanding of and treatment options for patients with this disease. In this review, the authors focus on novel therapeutic and diagnostic approaches in the perioperative setting, with an emphasis on ...
Wesley Yip   +8 more
wiley   +1 more source

PARP Inhibitors in the Treatment of Prostate Cancer: An Analysis of the Clinical Trial Landscape

open access: yesCancer Medicine, Volume 14, Issue 21, November 2025.
ABSTRACT Background Prostate cancer remains one of the most prevalent cancers among men worldwide, particularly in the context of metastatic castration‐resistant prostate cancer (mCRPC), which poses significant treatment challenges. PARP inhibitors offer a promising therapeutic option for patients with homologous recombination repair (HRR) deficiencies.
Yanru Chen   +7 more
wiley   +1 more source

Neurokinin-1 Receptor Antagonists for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review [PDF]

open access: bronze, 2012
Lucas Vieira dos Santos   +4 more
openalex   +1 more source

Assessment of chemotherapy-induced nausea and vomiting in pediatrics: Adequacy of control and adherence to guidelines

open access: gold, 2023
Sameh Awwad   +3 more
openalex   +1 more source

Effect of a standardized ginger root powder regimen on chemotherapy-induced nausea and vomiting: a multi-center double-blind placebo-controlled randomized trial.

open access: yesJournal of the Academy of Nutrition and Dietetics, 2023
Megan Crichton   +10 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy